Live from the NIH registry
Studies recruiting near Birmingham right now
Top 25 of 978 recruiting studies, sorted by proximity — each links to its official registry page
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
Amyotrophic Lateral Sclerosis
Phase 3
Interventional 495 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: AB Science
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Generalized Myasthenia Gravis
N/A
Observational 500 participants sought
Clinical Trial Site — Birmingham, Alabama (0.6 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
ViTAA Registry Pre- and Post-Operative Monitoring for Endovascular Aortic Aneurysm Repair and Serial Monitoring for AAA
Abdominal Aortic Aneurysms
N/A
Observational 200 participants sought
UAB - University of Alabama in Birmingham Hospital — Birmingham, Alabama (0.6 mi)
· Sponsor: ViTAA Medical Solutions
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Hematuria - Cause Not Known
N/A
Interventional 1,000 participants sought
Urology Centers of Alabama — Homewood, Alabama (3.9 mi)
· Sponsor: Pacific Edge Limited
Radiation Free Study
Aortic Aneurysm
N/A
Interventional 182 participants sought
University of Alabama — Birmingham, Alabama (0.6 mi)
· Sponsor: Philips Clinical & Medical Affairs Global
Evaluating an Interactive Digital Toolkit for Women's PrEP Implementation
HIV Prevention, HIV Risk
N/A
Interventional 125 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: University of Alabama at Birmingham
Process-Based Approach Case Series For Anxiety Problems
Anxiety
N/A
Interventional 10 participants sought
University of Alabama at Birmingham Dr. Borgogna's lab — Birmingham, Alabama (0.6 mi)
· Sponsor: University of Alabama at Birmingham
Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
NK-Cell Lymphoma, NK-Cell Leukemia
EARLY/Phase 1
Interventional 40 participants sought
University of Alabama — Birmingham, Alabama (0.6 mi)
· Sponsor: New York Medical College
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Veterans Administration Medical Center - Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: SWOG Cancer Research Network
RA-PRO PRAGMATIC TRIAL
Rheumatoid Arthritis
Phase 3
Interventional 924 participants sought
Bendcare, LLC — Birmingham, Alabama (0.6 mi)
· Sponsor: University of Alabama at Birmingham
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Phase 1, Phase 2
Interventional 260 participants sought
UAB Comprehensive Cancer Center — Birmingham, Alabama (0.6 mi)
· Sponsor: Bristol-Myers Squibb
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer
Phase 3
Interventional 590 participants sought
Alabama Oncology — Birmingham, Alabama (0.6 mi)
· Sponsor: Revolution Medicines, Inc.
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Phase 2
Interventional 164 participants sought
WISPer Site in Birmingham, AL — Birmingham, Alabama (0.6 mi)
· Sponsor: Mediar Therapeutics
A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors
Advanced Solid Tumor
Phase 1
Interventional 105 participants sought
University of Alabama At Birmingham Hospital — Birmingham, Alabama (0.6 mi)
· Sponsor: BeOne Medicines
A Study of Buntanetap in Participants With PD
Parkinson's Disease (PD), Deep Brain Stimulation
Phase 2, Phase 3
Interventional 500 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: Annovis Bio Inc.
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
Parkinson Disease
N/A
Observational 4,500 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: Michael J. Fox Foundation for Parkinson's Research
Diet Interventions: Remitted and Evaluated as Complementary Treatments for Pain
Knee Osteoarthritis
N/A
Interventional 200 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: University of Alabama at Birmingham
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Birmingham, Alabama (0.6 mi)
· Sponsor: AstraZeneca
Wavelength Intervention for Nearsighted Kids
Myopia
N/A
Interventional 80 participants sought
University of Alabama at Birmingham School of Optometry — Birmingham, Alabama (0.6 mi)
· Sponsor: University of Alabama at Birmingham
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: Jaeb Center for Health Research
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Birmingham, Alabama (0.6 mi)
· Sponsor: Sameek Roychowdhury
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
Rheumatoid Arthritis, Systemic Lupus Erythematosus
Phase 1
Interventional 48 participants sought
Research Site — Birmingham, Alabama (0.6 mi)
· Sponsor: AstraZeneca
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Overweight , Obesity, Adults
Phase 2
Interventional 220 participants sought
University of Alabama - Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: Alveus Therapeutics, Inc.
Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction
Heart Failure With Preserved Ejection Fraction
Phase 3
Interventional 2,000 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: Uppsala University
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
Myelodysplastic Syndrome, Acute Myeloid Leukemia
Phase 1
Interventional 178 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: Seagen, a wholly owned subsidiary of Pfizer